An2 Therapeutics Stock Price History

ANTX Stock  USD 1.37  0.02  1.44%   
If you're considering investing in AN2 Stock, it is important to understand the factors that can impact its price. As of today, the current price of AN2 Therapeutics stands at 1.37, as last reported on the 29th of November, with the highest price reaching 1.45 and the lowest price hitting 1.34 during the day. AN2 Therapeutics appears to be slightly risky, given 3 months investment horizon. AN2 Therapeutics retains Efficiency (Sharpe Ratio) of 0.11, which signifies that the company had a 0.11% return per unit of price deviation over the last 3 months. We have found twenty-nine technical indicators for AN2 Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of AN2 Therapeutics' Standard Deviation of 3.61, coefficient of variation of 1209.19, and Market Risk Adjusted Performance of 0.3485 to double-check if our risk estimates are consistent with your expectations.
  
At this time, AN2 Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 292.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 21.8 M in 2024. . Price Earnings Ratio is likely to drop to -7.84 in 2024. Price Book Value Ratio is likely to drop to 3.68 in 2024. AN2 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1123

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsANTX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.64
  actual daily
32
68% of assets are more volatile

Expected Return

 0.41
  actual daily
8
92% of assets have higher returns

Risk-Adjusted Return

 0.11
  actual daily
8
92% of assets perform better
Based on monthly moving average AN2 Therapeutics is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AN2 Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.4669
Book Value
4.193
Enterprise Value
-54.3 M
Enterprise Value Ebitda
(2.11)
Shares Float
11.4 M

AN2 Therapeutics Stock Price History Chart

There are several ways to analyze AN2 Stock price data. The simplest method is using a basic AN2 candlestick price chart, which shows AN2 Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 25, 20241.39
Lowest PriceNovember 14, 20241.0

AN2 Therapeutics November 29, 2024 Stock Price Synopsis

Various analyses of AN2 Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AN2 Stock. It can be used to describe the percentage change in the price of AN2 Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AN2 Stock.
AN2 Therapeutics Price Daily Balance Of Power(0.18)
AN2 Therapeutics Price Action Indicator(0.03)
AN2 Therapeutics Price Rate Of Daily Change 0.99 

AN2 Therapeutics November 29, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in AN2 Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use AN2 Therapeutics intraday prices and daily technical indicators to check the level of noise trading in AN2 Stock and then apply it to test your longer-term investment strategies against AN2.

AN2 Stock Price History Data

The price series of AN2 Therapeutics for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 0.39 with a coefficient of variation of 8.06. The prices are distributed with arithmetic mean of 1.09. The median price for the last 90 days is 1.06. The company issued dividends on 2018-01-11.
OpenHighLowCloseVolume
11/29/2024
 1.38  1.45  1.34  1.37 
11/27/2024 1.38  1.45  1.34  1.37  575,211 
11/26/2024 1.40  1.41  1.37  1.39  309,389 
11/25/2024 1.35  1.45  1.35  1.39  484,742 
11/22/2024 1.26  1.42  1.26  1.34  1,250,070 
11/21/2024 1.30  1.46  1.20  1.23  3,754,789 
11/20/2024 1.07  1.33  1.07  1.30  5,552,146 
11/19/2024 1.03  1.11  1.00  1.06  2,079,114 
11/18/2024 1.00  1.03  0.98  1.00  726,207 
11/15/2024 1.00  1.04  0.99  1.00  1,247,439 
11/14/2024 1.03  1.03  0.99  1.00  697,979 
11/13/2024 1.06  1.07  0.99  1.01  1,318,729 
11/12/2024 1.08  1.11  1.05  1.06  475,458 
11/11/2024 1.11  1.12  1.08  1.09  1,106,916 
11/08/2024 1.11  1.12  1.09  1.10  868,018 
11/07/2024 1.10  1.11  1.10  1.10  51,895 
11/06/2024 1.10  1.11  1.09  1.10  105,502 
11/05/2024 1.09  1.10  1.08  1.09  114,641 
11/04/2024 1.08  1.09  1.07  1.08  138,410 
11/01/2024 1.09  1.09  1.08  1.08  132,451 
10/31/2024 1.08  1.10  1.08  1.08  118,955 
10/30/2024 1.12  1.12  1.08  1.09  138,179 
10/29/2024 1.10  1.14  1.09  1.11  256,467 
10/28/2024 1.09  1.12  1.07  1.10  249,026 
10/25/2024 1.07  1.08  1.06  1.07  59,860 
10/24/2024 1.09  1.09  1.07  1.07  97,763 
10/23/2024 1.08  1.09  1.06  1.08  133,466 
10/22/2024 1.07  1.10  1.06  1.08  178,807 
10/21/2024 1.06  1.12  1.06  1.08  631,069 
10/18/2024 1.03  1.07  1.03  1.05  192,399 
10/17/2024 1.07  1.07  1.03  1.03  307,515 
10/16/2024 1.05  1.08  1.04  1.06  247,992 
10/15/2024 1.03  1.05  1.03  1.05  62,220 
10/14/2024 1.06  1.06  1.03  1.03  60,915 
10/11/2024 1.03  1.07  1.03  1.05  140,605 
10/10/2024 1.04  1.05  1.03  1.04  34,901 
10/09/2024 1.05  1.06  1.03  1.04  102,610 
10/08/2024 1.04  1.06  1.03  1.04  159,065 
10/07/2024 1.06  1.07  1.04  1.04  101,968 
10/04/2024 1.04  1.08  1.03  1.07  196,255 
10/03/2024 1.05  1.07  1.03  1.04  126,223 
10/02/2024 1.03  1.06  1.03  1.05  45,707 
10/01/2024 1.06  1.09  1.03  1.05  116,610 
09/30/2024 1.08  1.08  1.06  1.07  135,525 
09/27/2024 1.06  1.09  1.06  1.06  175,519 
09/26/2024 1.06  1.07  1.03  1.06  197,136 
09/25/2024 1.06  1.06  1.03  1.05  262,504 
09/24/2024 1.05  1.09  1.04  1.04  360,449 
09/23/2024 1.06  1.08  1.04  1.04  60,466 
09/20/2024 1.08  1.08  1.05  1.05  311,847 
09/19/2024 1.07  1.08  1.05  1.08  384,418 
09/18/2024 1.07  1.09  1.05  1.06  252,671 
09/17/2024 1.05  1.07  1.05  1.06  170,967 
09/16/2024 1.05  1.07  1.04  1.05  165,462 
09/13/2024 1.03  1.06  1.02  1.04  219,275 
09/12/2024 1.05  1.06  1.01  1.04  159,873 
09/11/2024 1.04  1.06  1.03  1.04  148,986 
09/10/2024 1.05  1.06  1.03  1.03  113,673 
09/09/2024 1.01  1.08  1.01  1.04  245,912 
09/06/2024 1.04  1.05  1.01  1.02  429,211 
09/05/2024 1.04  1.06  1.01  1.03  702,389 

About AN2 Therapeutics Stock history

AN2 Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AN2 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AN2 Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AN2 Therapeutics stock prices may prove useful in developing a viable investing in AN2 Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding23.6 M21.8 M
Net Loss-38.5 M-40.4 M

AN2 Therapeutics Quarterly Net Working Capital

87.67 Million

AN2 Therapeutics Stock Technical Analysis

AN2 Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AN2 Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AN2 Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

AN2 Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for AN2 Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AN2 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AN2 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for AN2 Stock Analysis

When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.